177 related articles for article (PubMed ID: 161647)
1. [Various fibrinolytic and coagulation characteristics of the blood plasma after contact with N-amyl alcohol].
Lussa A; Tymińska-Brzósko R
Rocz Akad Med Im Juliana Marchlewskiego Bialymst; 1979; 24():91-104. PubMed ID: 161647
[No Abstract] [Full Text] [Related]
2. Monitoring activity of fibrinolytic agents. A therapeutic challenge.
Shafer KE; Santoro SA; Sobel BE; Jaffe AS
Am J Med; 1984 May; 76(5):879-86. PubMed ID: 6232847
[TBL] [Abstract][Full Text] [Related]
3. Proceedings: Fibrinogen degradation of normal and fibrinolytic plasma.
Scully MF; Kakkar VV
Thromb Diath Haemorrh; 1975 Nov; 34(2):584. PubMed ID: 53894
[No Abstract] [Full Text] [Related]
4. [Effect of the enzyme preparation longolytin on fibrinolysis in animals].
Serebriakova TN; Andreenko GV; Tsymanovich SG; Maksimova RA; Sharkova TS
Nauchnye Doki Vyss Shkoly Biol Nauki; 1985; (2):66-71. PubMed ID: 3157406
[TBL] [Abstract][Full Text] [Related]
5. [Effect of a single administration of plasminogen tissue activator on the state of the fibrinolytic system of rat blood].
Andreenko GV; Shimonaeva EE; Liutova LV; Serebriakova TN
Vopr Med Khim; 1981; 27(1):77-80. PubMed ID: 7193381
[TBL] [Abstract][Full Text] [Related]
6. The coagulation and fibrinolytic responses of baboons after in vivo thrombin generation--effect of interleukin 6.
Kruithof EK; Mestries JC; Gascon MP; Ythier A
Thromb Haemost; 1997 May; 77(5):905-10. PubMed ID: 9184401
[TBL] [Abstract][Full Text] [Related]
7. Comparison of the relative fibrinogenolytic, fibrinolytic and thrombolytic properties of tissue plasminogen activator and urokinase in vitro.
Matsuo O; Rijken DC; Collen D
Thromb Haemost; 1981 Jun; 45(3):225-9. PubMed ID: 7025339
[TBL] [Abstract][Full Text] [Related]
8. Selection of S18326 as a new potent and selective boronic acid direct thrombin inhibitor.
Rupin A; Mennecier P; Lila C; de Nanteuil G; Verbeuren TJ
Thromb Haemost; 1997 Oct; 78(4):1221-7. PubMed ID: 9364988
[TBL] [Abstract][Full Text] [Related]
9. [Fibrinolytic system of animals repeatedly and chronically administered plasminogen tissue activator].
Shimonaeva EE; Liutova LV; Andreenko GV
Vopr Med Khim; 1981; 27(6):823-8. PubMed ID: 7199779
[TBL] [Abstract][Full Text] [Related]
10. [Blood coagulating properties of immobilized proteases].
Zubairov DM; Zinkevich OD
Vopr Med Khim; 1976; 22(2):187-91. PubMed ID: 140525
[TBL] [Abstract][Full Text] [Related]
11. Exercise-induced fibrinolysis--fact or fiction?
Marsh NA; Gaffney PJ
Thromb Haemost; 1982 Oct; 48(2):201-3. PubMed ID: 6217583
[TBL] [Abstract][Full Text] [Related]
12. Proceedings: Fibrinolysis versus fibrinogenolysis: the specificity of human vascular activator (VA) as compared to urokinase (UK) and streptokinase (SK).
Lipinski B; Gurewich V; Hyde E
Thromb Diath Haemorrh; 1975 Sep; 34(1):351. PubMed ID: 1188799
[No Abstract] [Full Text] [Related]
13. [Possibilities of early diagnosis of thromboembolic complications in myocardial infarct by means of biochemical methods].
Andreenko GV; Bessolitsyna LA; Sargin KE
Kardiologiia; 1977 Jan; 17(1):98-103. PubMed ID: 140260
[TBL] [Abstract][Full Text] [Related]
14. Substrate composition and the effect of epsilon-aminocaproic acid on tissue plasminogen activator and urokinase-induced fibrinolysis.
Thorsen S; Astrup T
Thromb Diath Haemorrh; 1974 Dec; 32(2-3):306-24. PubMed ID: 4281113
[No Abstract] [Full Text] [Related]
15. Thrombin activatable fibrinolysis inhibitor (TAFI) affects fibrinolysis in a plasminogen activator concentration-dependent manner. Study of seven plasminogen activators in an internal clot lysis model.
Guimarães AH; Rijken DC
Thromb Haemost; 2004 Mar; 91(3):473-9. PubMed ID: 14983222
[TBL] [Abstract][Full Text] [Related]
16. [Serial changes in hemostatic and fibrinolytic states induced by coronary thrombolytic therapy].
Goto S; Handa S; Abe S; Takahashi E; Kawai Y; Watanabe K; Yoshikawa T; Hori S; Ikeda Y
J Cardiol; 1993; 23(4):335-41. PubMed ID: 8064582
[TBL] [Abstract][Full Text] [Related]
17. [Fibrinolytic system in patients with nephrotic syndrome].
Andreenko GV; Poliantseva LR; Smirnova TA; Podorol'skaia LV
Ter Arkh; 1976; 40(2):89-99. PubMed ID: 135367
[No Abstract] [Full Text] [Related]
18. Effects of pro-urokinase and urokinase on the fibrinolytic system in man.
Trübestein G; Popov S; Wolf H; Welzel D
Haemostasis; 1987; 17(4):238-44. PubMed ID: 2442078
[TBL] [Abstract][Full Text] [Related]
19. [Determination of the enzyme activity of the fibrinolytic system using fibrinogen conjugated with peroxidase].
Liaginskiĭ AV; AfanasenkoGA ; Gudkova EV
Lab Delo; 1991; (11):27-31. PubMed ID: 1722843
[TBL] [Abstract][Full Text] [Related]
20. In vitro effects of aspirin in fibrinolysis.
Iatridis PG; Iatridis SG; Markidou SG; Ragatz BH
Haemostasis; 1974; 3(1):55-64. PubMed ID: 4279872
[No Abstract] [Full Text] [Related]
[Next] [New Search]
